BLCM Chart
- 52-Week Range: $1.35 - $3.66
- Market Capitalization: $13.60M
- Short Percentage: 0%
- Target Price: $5.00
- Shares Outstanding: 8.61M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
BLCM released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational UpdateGlobeNewsWire | March 24th
- Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology ConferenceGlobeNewsWire | January 26th
- Bellicum Regains Compliance with Nasdaq Continued Listing RequirementsGlobeNewsWire | December 13th
- Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational UpdateGlobeNewsWire | November 4th
- Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire | September 3rd
- Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety SwitchGlobeNewsWire | September 1st
- Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | July 26th
Company Info
Website: https://www.bellicum.com
Address: 3730 Kirby Drive, Houston, TX, United States, 77098
Sector: Healthcare
Industry: Biotechnology
Full time employees: 7
Address: 3730 Kirby Drive, Houston, TX, United States, 77098
Sector: Healthcare
Industry: Biotechnology
Full time employees: 7
$BLCM The United States stock market is going to crash.
$BLCM cover that shit
$BLCM finally a pullback
$BLCM Short again!! 😀 😀
$BLCM I’m selling y’all have fun bag holding
$BLCM buy buy buy!!
$BLCM let’s go!! Squeeze time
$BLCM Buying puts at open